1. INVESTOR PRESENTATION

2. Disclaimer
This Investor Presentation has been prepared by VOS HEALTHCARE LLC, USA . For investors, solely for informational
purposes.
The information contained herein has been prepared to assist prospective investors in making their own evaluation of the Company and does no
purport to be all-inclusive or to contain all of the information a prospective or existing investor may desire. In all cases, interested parties should
conduct their own investigation and analysis of the Company and the data set forth in this information. VOS makes no representation or warran
the accuracy or completeness of this information and shall not have any liability for any representations (expressed or implied) regarding informa
contained in, or for any omissions from, this information or any other written or oral communications transmitted to the recipient in the course of
evaluation of the Company.
This Information includes certain statements and estimates provided by the Company with respect to the projected future performance of the
Company. Such statements, estimates and projections reflect various assumptions by management concerning possible anticipated results, whi
assumptions may or may not be correct. No representations are made as to the accuracy of such statements, estimates or projections. Prospec
investors will be expected to have conducted their own due diligence investigation regarding these and all other matters pertinent to investment
Company.
This presentation may contain statements that are not historical facts, referred to as “forward looking statements.” The corporation’s actual futur
results may differ materially from those suggested by such statements, depending on various factors including those described in filings made w
SEC.
2

3. EXECUTIVE SUMMARY AND GROWTH PLATFORM

4. Mission
NaSCF goal is to be the largest STEM CELL THERAPY AND BANKING services player in the world.
CONVERGENCE
The company’s technology vision is to focus on convergence of all STEM CELL THERAPY and STEM CELL BANKING in a manner that
Patient can seamlessly get treatment or services at door step. . The company intends to do that by designing products and services that
are pioneering and at least a few years ahead of its competition. The company believes that profitability and revenue growth must go hand
in hand.
With no competitors who can match the completeness of its vision or its distinct advantages, NaSCF is ideally positioned to seize an
enormous “green field” opportunity. Continually cited for the high quality of its offering, NaSCF has built an outstanding reputation among
a large, impressive customer base. With a strong recurring, Stem Cell therapy as a Therapeutic Cure model, NaSCF is positioned to be a
leading player in the Healthcare, surely moving towards the disease free world
4

5. VOS HEALTHCARE Introduction
VOS Healthcare Pvt Ltd (India)(the “Company”) was founded in 2011 by VOS Healthcare LLC, USA, a Washington corporation.
VOS Healthcare LLC, USA is a leading provider of Adult Stem cell therapy and Regenerative medicine and Stem Cell Banking
( Cord Blood and Menstrual blood banking). VOS provides therapeutic as well as storing facilities all over the globe. Our
services are ranging from collection, transportation, carrier systems, sterile environment for packaging, laboratory and centers,
Banking of Stem cell along with a solutions storing for variety of period and flexibility of payment all across the globe. VOS
powers multiple exchanges across the world in the field of Autologous Stem cell Production, Differentiations, Newer research
Treatment and Research in Biopharma conducting in excess of $100 billion at the possible sector of business on its platforms
VOS’s goal is to be the leading backend powerhouse of STEM CELL THERAPY in the world. The Company’s healthcare vision is to
focus on convergence of all possible therapies in Stem cell, processes of Stem Cell Banking, Culturing and Differentiation of the
stem cell, Derivation and Perpetuating in to Tissue Specific Cell, Cell cytometeric counting, Sterile chain and delivery to the
patient all these in a manner such that viability and sterility is maintained and the complete complex function can seamlessly
flow once the collection of Stem cell has been made.
With a recurring revenue base in excess of 75% +, VOS strives to work collaboratively with clients to develop innovative
technology strategies and solutions that address specific business challenges. VOS combines the newest technologies with its
capabilities in distant consulting, Advance Research and Cell therapy design and integration, Franchising and business to meet
the individual needs of patients and with the continuous changes occurring in the diseases grading and presentation and its
treatment.
The Company has its headquarters in Seattle, Washington, and has domestic operations in New Jersey, Pittsburgh. The
Company also has offices in four other countries namely Australia, England, Poland and India. Through its various VOS based
Services platforms, VOS employs 300 professionals providing products, support and counselling to thousands of customers on
six continents across 50+ countries.
VOS’s focus on quality has enabled its development unit in India to be awarded Level 5 status of the University of Pittsburgh
Medical Center’s Capability. The Company has received numerous awards and recognition from its Healthcare industry, the
media, and by customers including being ranked very high in the top 100 fastest growing companies in the world
5

6. Summary Highlights
Industry Leadership Opportunity by Leveraging VOS’s Strong Market Presence. The U.S. Healthcare market is a highly fragmented
$360
billion industry. VOS’s innovative Adult Stem cell Therapy and its global reach, positions it as a possible leader in the worldwide Regenerative
Medicince markets
.Large, Impressive Client Base for Expansion and Cross-selling. VOS’s outstanding reputation with a large customer base and community
of
healthcare professionals offers tremendous expansion and cross-reffering opportunities to accelerate an already very strong market position
One of the Most Successful Regenerative Medicine Companies in the United States in terms of its consistency of results. VOS healthcare has
achieved consistently growing financial metrics for revenues, profits, margins, etc. With a fully post-split diluted EPS of $0.41 for the Q3 of 2011 as
compared to $0.43 in the Q3 of 2010 and $1.51 for the year 2010, VOS has set a very high benchmark for itself. The full year cumulative diluted EPS
for 2010 grew by 47% as
compared to cumulative diluted EPS of $1.03 for the year 2009.
High Growth and Profitable Recurring Revenue Model. With over 75% of its revenue generated from recurring sources, derived from a 99%
plus customer retention rate, VOS has a solid revenue base to build upon affording a high degree of visibility to its growth and future revenues. With
2010 2009 2008 2010 2009 2008
35% revenue 2010 2009 2008 2007 Operating 41% 2009 2008
30% 2007 23% 2006
2010 2009 2008
Margins
growth in 2010 and net income growth of 52% on a year-over-year basis, VOS has continued to post record-setting numbers in terms of income and
Operating Margins 41% 30% 23%
EPS 2011 Q3 Q2 Q1 Q42010
Net income in thousand 42 9 1
$ Consistency of Performance over the last many years. Operating Margins 42% 44% 39% 39%
Growth of 2010 over 52% 116% 365%
other years
Diluted EPS in $ 1.52 1.03 0.36
Q3 2011 Q2 2011 Q1 2011 Q4 2010
Growth of 2010 over 39% 99% 278%
other years
(Diluted earnings per share reflects the 3-for-1 stock split effective January 5, 2010)
6

7. Summary Highlights
Unique Differentiation Enhances VOS Healthcare’s Leadership Opportunity
VOS Healthcare’s exchanges power transactions between hundreds of thousands of patients for these services of stem
cell banking and therapy.
VOS Healthcare’s services extends close to 0.15 million patients every year. VOS Healthcare’s revenue turnaround sums in excess of
$0.5 million in the United States along with overseas business. In Australia the majority of VOS Healthcare work focuses on the Stem
cell Therapy especially on diabetes and cancer treatment. VOS Healthcare’s on-demand Menstrual and Adipose Banking used by
100,000 plus users around the world. With the aggregation of a large community of Stem Cell banking and therapeutics , VOS
Healthcare is seen as a Mentor to Stem Cell markets by these entities. Many Countries are still out of reach of VOS Healthcare
Regenerative Medicine services , gives us a chance to expand and work harder to reach every corner of the globe.
VOS Healthcare has a global reach in Regenerative Medicine knowledge.
VOS Healthcare powers businesses in more than 50 countries today across six continents. VOS Healthcare has a global footprint with
in excess of 10+ offices today world-wide.
VOS Healthcare provides a multi-layer centers(Bud and Root collection center)and advanced lab and research labs with
world-wide quick co-ordination and support, unlike any other player in the regenerative industry that addresses these
markets.
VOS Healthcare systems are multi-lingual, multi-currency and work in French, Portuguese, Spanish, Japanese, Chinese and English.
With fully owned offshore facilities in India, VOS Healthcare has the ability to reduce the cost structure of acquired
companies and increase their efficiency.
VOS Healthcare’s centers in India have Carnegie Mellon’s highest CMMI 5 rating and that establishes the quality of VOS Healthcare’s
operations to any of its prospective customers
Experienced Executive Management Team with Health Expertise and Industry Recognition.
VOS Healthcare’s team includes Physicians, Physician Research, Biotechnologists, Biologist, Nurses and Other accessories Staff with a
deep understanding of the Regenerative Medicine spanning an ample of years of experience amongst them. Its infrastructure and
experienced executive management team is highly capable of sustaining its leadership and developing VOS Healthcare into an even
larger organization.
7

8. Global Footprint
Our markets and our clients cross geographic boundaries. VOS employs hundreds of insurance & technology professionals providin
products, support and consultancy to thousands of customers on six continents across 50+ countries through 30+ offices.
8

9. Welcome Investor
For detailed presentation, please fill up the form here…
Thanks!
Your Trustworthy
VOS Team